Selecting the right patients for testing novel agents in hepatocellular carcinoma: who, when and how?
Author:
Affiliation:
1. State Key Laboratory in Oncology in South China; Sir YK Pao Center for Cancer; Department of Clinical Oncology; Hong Kong Cancer Institute and Prince of Wales Hospital; the Chinese University of Hong Kong; China
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12061/fullpdf
Reference28 articles.
1. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study;Liaw;Gastroenterology,1986
2. Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma;Chan;Liver Int,2012
3. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers;Wong;J Clin Oncol,2010
4. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma;Yeo;J Natl Cancer Inst,2005
5. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy;Chan;J Clin Oncol,2009
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2016-07
2. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2015-09-11
3. International validation of the Chinese University Prognostic Index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong study;Chinese Journal of Cancer;2014-09-16
4. Development of systemic therapy for hepatocellular carcinoma at 2013: Updates and insights;World Journal of Gastroenterology;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3